Search research articles
Contact Us
Filters
Showing results (461-470 of 550) with videos related to
Page
of 55
Sort By:
American Journal of Surgery
|
May 3, 2005
The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer
Philip S Mullenix, Tommy A Brown, Micheal O Meyers, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
January 18, 2005
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts
L Chilton, S Ohya, D Freed, et al.
Frontiers in Neurology
|
December 1, 2022
Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors
Bradley S Hollidge, Hayley B Carroll, Randolph Qian, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 15, 1987
Use of platelet concentrate in eastern Ontario
S S Silver, G Rock, F Décary, et al.
Frontiers in Physiology
|
May 2, 2019
Atmospheric Electricity Influencing Biogeochemical Processes in Soils and Sediments
Ellard R Hunting, R Giles Harrison, Andreas Bruder, et al.
Cell
|
November 11, 1999
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
S Minamisawa, M Hoshijima, G Chu, et al.
Chest
|
September 25, 2007
Standardization of the single-breath diffusing capacity in a multicenter clinical trial
Robert A Wise, John G Teeter, Robert L Jensen, et al.
Optics Express
|
April 8, 2010
All-optical XOR and XNOR operations at86.4 Gb/s using a pair of semiconductor optical amplifier Mach-Zehnder interferometers
I Kang, M Rasras, L Buhl, et al.
Ophthalmology
|
June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial
Eric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
JAMA Ophthalmology
|
March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial
Eric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Page
of 55
Search research articles
Search
Showing results (461-470 of 550) with videos related to
Sort By:
Page
of 55
American Journal of Surgery
|
May 3, 2005
The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer
Philip S Mullenix, Tommy A Brown, Micheal O Meyers, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
January 18, 2005
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts
L Chilton, S Ohya, D Freed, et al.
Frontiers in Neurology
|
December 1, 2022
Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors
Bradley S Hollidge, Hayley B Carroll, Randolph Qian, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 15, 1987
Use of platelet concentrate in eastern Ontario
S S Silver, G Rock, F Décary, et al.
Frontiers in Physiology
|
May 2, 2019
Atmospheric Electricity Influencing Biogeochemical Processes in Soils and Sediments
Ellard R Hunting, R Giles Harrison, Andreas Bruder, et al.
Cell
|
November 11, 1999
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
S Minamisawa, M Hoshijima, G Chu, et al.
Chest
|
September 25, 2007
Standardization of the single-breath diffusing capacity in a multicenter clinical trial
Robert A Wise, John G Teeter, Robert L Jensen, et al.
Optics Express
|
April 8, 2010
All-optical XOR and XNOR operations at86.4 Gb/s using a pair of semiconductor optical amplifier Mach-Zehnder interferometers
I Kang, M Rasras, L Buhl, et al.
Ophthalmology
|
June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial
Eric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
JAMA Ophthalmology
|
March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial
Eric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Page
of 55